PMID- 8022822 OWN - NLM STAT- MEDLINE DCOM- 19940801 LR - 20191210 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 91 IP - 14 DP - 1994 Jul 5 TI - Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. PG - 6569-73 AB - BCL-2 is a 26-kDa integral membrane protein that represses apoptosis by an unknown mechanism. Recent findings indicate that Ca2+ release from the endoplasmic reticulum (ER) mediates apoptosis in mouse lymphoma cells. In view of growing evidence that BCL-2 localizes to the ER, as well as mitochondria and the perinuclear membrane, we investigated the possibility that BCL-2 represses apoptosis by regulating Ca2+ fluxes through the ER membrane. A cDNA encoding BCL-2 was introduced into WEHI7.2 cells and two subclones, W.Hb12 and W.Hb13, which express high and low levels of BCL-2 mRNA and protein, respectively, were isolated. WEHI7.2 cells underwent apoptosis in response to treatment with the glucocorticoid hormone dexamethasone, whereas W.Hb12 and W.Hb13 cells were protected from apoptosis, revealing a direct relationship between the level of BCL-2 expression and the degree of protection. Significantly, BCL-2 also blocked induction of apoptosis by thapsigargin (TG), a highly specific inhibitor of the ER-associated Ca2+ pump. TG completely inhibited ER Ca2+ pumping in both WEHI7.2 and W.Hb12 cells, but the release of Ca2+ into the cytosol after inhibition of ER Ca2+ pumping was significantly less in W.Hb12 cells than in WEHI7.2 cells, indicating that BCL-2 reduces Ca2+ efflux through the ER membrane. By reducing ER Ca2+ efflux, BCL-2 interfered with a signal for "capacitative" entry of extracellular Ca2+, preventing a sustained increase of cytosolic Ca2+ in TG-treated cells. These findings suggest that BCL-2 either directly or indirectly regulates the flux of Ca2+ across the ER membrane, thereby abrogating Ca2+ signaling of apoptosis. FAU - Lam, M AU - Lam M AD - Department of Medicine, Case Western Reserve University, Cleveland, OH 44106. FAU - Dubyak, G AU - Dubyak G FAU - Chen, L AU - Chen L FAU - Nunez, G AU - Nunez G FAU - Miesfeld, R L AU - Miesfeld RL FAU - Distelhorst, C W AU - Distelhorst CW LA - eng GR - CA42755/CA/NCI NIH HHS/United States GR - GM36387/GM/NIGMS NIH HHS/United States GR - GM40738/GM/NIGMS NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Proto-Oncogene Proteins) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (RNA, Messenger) RN - 0 (Terpenes) RN - 67526-95-8 (Thapsigargin) RN - 7S5I7G3JQL (Dexamethasone) RN - EC 3.6.1.- (GTP-Binding Proteins) RN - EC 7.2.2.10 (Calcium-Transporting ATPases) RN - KOO5CM684H (Digitonin) RN - SY7Q814VUP (Calcium) SB - IM GS - Bcl-2 GS - ced-3 GS - ced-4 GS - ced-9 MH - Apoptosis/*physiology MH - Calcium/*metabolism MH - Calcium-Transporting ATPases/antagonists & inhibitors/*metabolism MH - Cell Line MH - Cell Membrane Permeability MH - Cell Survival/drug effects MH - Clone Cells MH - Dexamethasone/pharmacology MH - Digitonin MH - Endoplasmic Reticulum/*metabolism MH - GTP-Binding Proteins/metabolism MH - Humans MH - Kinetics MH - Proto-Oncogene Proteins/biosynthesis/*metabolism MH - Proto-Oncogene Proteins c-bcl-2 MH - *Proto-Oncogenes MH - RNA, Messenger/*biosynthesis MH - Terpenes/pharmacology MH - Thapsigargin MH - Time Factors MH - Transfection PMC - PMC44244 EDAT- 1994/07/05 00:00 MHDA- 1994/07/05 00:01 PMCR- 1995/01/05 CRDT- 1994/07/05 00:00 PHST- 1994/07/05 00:00 [pubmed] PHST- 1994/07/05 00:01 [medline] PHST- 1994/07/05 00:00 [entrez] PHST- 1995/01/05 00:00 [pmc-release] AID - 10.1073/pnas.91.14.6569 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6569-73. doi: 10.1073/pnas.91.14.6569.